Difference between revisions of "Category:Mutation-specific medications"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
 
Line 1: Line 1:
Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific mutations.
+
Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific gene mutations.
  
 
[[Category:Biomarker-specific medications]]
 
[[Category:Biomarker-specific medications]]

Latest revision as of 17:07, 10 January 2020

Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific gene mutations.

Pages in category "Mutation-specific medications"

The following 69 pages are in this category, out of 69 total.